Taiwan · Delayed Price · Currency is TWD Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 13.62 billion. The enterprise value is 9.90 billion.
| Market Cap | 13.62B |
| Enterprise Value | 9.90B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
TPEX:6620 has 166.53 million shares outstanding. The number of shares has increased by 12.71% in one year.
| Current Share Class | 166.53M |
| Shares Outstanding | 166.53M |
| Shares Change (YoY) | +12.71% |
| Shares Change (QoQ) | +5.30% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 2.17% |
| Float | 97.01M |
Valuation Ratios
The trailing PE ratio is 16.84.
| PE Ratio | 16.84 |
| Forward PE | n/a |
| PS Ratio | 7.75 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 3.00 |
| P/FCF Ratio | 42.11 |
| P/OCF Ratio | 37.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.86, with an EV/FCF ratio of 30.61.
| EV / Earnings | 12.68 |
| EV / Sales | 5.63 |
| EV / EBITDA | 8.86 |
| EV / EBIT | 10.36 |
| EV / FCF | 30.61 |
Financial Position
The company has a current ratio of 8.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.91 |
| Quick Ratio | 8.83 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.14 |
| Interest Coverage | 863.51 |
Financial Efficiency
Return on equity (ROE) is 18.58% and return on invested capital (ROIC) is 42.61%.
| Return on Equity (ROE) | 18.58% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 42.61% |
| Return on Capital Employed (ROCE) | 17.63% |
| Weighted Average Cost of Capital (WACC) | 8.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6620 has paid 196.27 million in taxes.
| Income Tax | 196.27M |
| Effective Tax Rate | 20.09% |
Stock Price Statistics
The stock price has decreased by -3.42% in the last 52 weeks. The beta is 0.73, so TPEX:6620's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -3.42% |
| 50-Day Moving Average | 73.15 |
| 200-Day Moving Average | 92.46 |
| Relative Strength Index (RSI) | 72.07 |
| Average Volume (20 Days) | 534,820 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 1.76 billion and earned 780.80 million in profits. Earnings per share was 4.86.
| Revenue | 1.76B |
| Gross Profit | 1.49B |
| Operating Income | 952.45M |
| Pretax Income | 977.07M |
| Net Income | 780.80M |
| EBITDA | 1.10B |
| EBIT | 952.45M |
| Earnings Per Share (EPS) | 4.86 |
Balance Sheet
The company has 3.77 billion in cash and 46.00 million in debt, with a net cash position of 3.72 billion or 22.34 per share.
| Cash & Cash Equivalents | 3.77B |
| Total Debt | 46.00M |
| Net Cash | 3.72B |
| Net Cash Per Share | 22.34 |
| Equity (Book Value) | 5.29B |
| Book Value Per Share | 31.75 |
| Working Capital | 3.81B |
Cash Flow
In the last 12 months, operating cash flow was 358.67 million and capital expenditures -35.18 million, giving a free cash flow of 323.49 million.
| Operating Cash Flow | 358.67M |
| Capital Expenditures | -35.18M |
| Depreciation & Amortization | 149.63M |
| Net Borrowing | -13.19M |
| Free Cash Flow | 323.49M |
| FCF Per Share | 1.94 |
Margins
Gross margin is 84.83%, with operating and profit margins of 54.18% and 44.41%.
| Gross Margin | 84.83% |
| Operating Margin | 54.18% |
| Pretax Margin | 55.58% |
| Profit Margin | 44.41% |
| EBITDA Margin | 62.69% |
| EBIT Margin | 54.18% |
| FCF Margin | 18.40% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.44%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 30.26% |
| Buyback Yield | -12.71% |
| Shareholder Yield | -10.03% |
| Earnings Yield | 5.73% |
| FCF Yield | 2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6620 has an Altman Z-Score of 16.34 and a Piotroski F-Score of 2.
| Altman Z-Score | 16.34 |
| Piotroski F-Score | 2 |